Latest news

Manufacturing

Lilly Adds $4.5 Billion to Indiana Manufacturing Expansion, Total U.S. Commitments Exceed $50 Billion

Eli Lilly has announced an additional $4.5 billion investment to expand two of its three manufacturing facilities under development...
Commercial

Madrigal Licenses ARO-PNPLA3 from Arrowhead in Deal Worth Up to $1 Billion

Madrigal Pharmaceuticals has entered into a licensing agreement with Arrowhead Pharmaceuticals to obtain rights to ARO-PNPLA3, an RNA interference...
Regulatory

Viridian’s Tepezza Competitor Hits Another Phase 3 Win; Door Opens For FDA Nod

Viridian Therapeutics has reported success in a second phase 3 study of its anti-IGF-1R antibody, strengthening its position as...
Clinical

Myqorzo from Cytokinetics wins historic cardiomyopathy trial

Robert Blum and Fady Malik have been with Cytokinetics since its inception almost 30 years ago. By achieving both...
Commercial

Amgen Adds $300 Million to Puerto Rico Expansion, Bringing U.S. Investment Commitments Near $2 Billion

Amgen has announced an additional $300 million investment to...
Clinical

Gedatolisib from Celcuity outperforms Piqray from Novartis in phase 3 research

A phase 3 trial of a pan-PI3K/mTOR inhibitor, Celcuity,...
Clinical

Takeda Reports Phase 2/3 Data Showing TAK-881 Comparable to HyQvia in Primary Immunodeficiency Disease

Takeda has reported that its investigational therapy TAK-881 met the primary endpoint in a phase 2/3 clinical study, demonstrating...
Insights

Top 10 High-Impact Careers Defining the Future of Life Sciences

Executive Summary The life sciences workforce in 2026 is being reshaped by AI integration, advanced therapeutics, regulatory complexity, and commercialization...
Clinical

In a late-stage trial, Intellia’s gene treatment for rare condition reduces swelling attacks

Intellia Therapeutics has announced that its experimental gene-editing drug reduced the number of swelling attacks in patients with a...
Clinical

Boehringer Reports Phase 3 Data on Survodutide Showing 16.6% Weight Loss at Week 76

Boehringer Ingelheim has reported results from a phase 3...
Regulatory

Revolution Challenges Erasca’s ERAS-0015 Over Patent and Data Comparison Claims

Revolution Medicines has raised legal and competitive concerns against...
Manufacturing

Lilly and Profluent Sign Up to $2.25 Billion Collaboration to Develop AI-Designed Genetic Medicines

Eli Lilly has entered into a multi-program research collaboration with California-based Profluent to develop genetic medicines using artificial intelligence-designed...
Clinical

Novartis and PTC Advance Huntington’s Drug Votoplam to Phase 3 Following Mid-Stage Data

Novartis and PTC Therapeutics have moved their Huntington’s disease candidate, votoplam, into Phase 3 development after results from a...
Commercial

Chiesi to Acquire KalVista for $1.9 Billion, Adding Oral HAE Therapy Ekterly

Italy-based Chiesi Group has agreed to acquire KalVista Pharmaceuticals in a deal valued at approximately $1.9 billion, securing access...
Regulatory

Viridian’s Tepezza Competitor Hits Another Phase 3 Win; Door Opens For FDA Nod

Viridian Therapeutics has reported success in a second phase...
Editorial Team -
Commercial

Madrigal Licenses ARO-PNPLA3 from Arrowhead in Deal Worth Up to $1 Billion

Madrigal Pharmaceuticals has entered into a licensing agreement with...
Editorial Team -
Commercial

Triana Biomedicines Secures $120 Million Series B to Advance Lead Molecular Glue Degrader

Triana Biomedicines has raised $120 million in a series...
Commercial

Miromatrix and Baxter Collaborate to Advance Care for Patients with Acute Liver Failure

An official statement was made public regarding a collaborative...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team -

Regulatory

Regulatory

Viridian’s Tepezza Competitor Hits Another Phase 3 Win; Door Opens For FDA Nod

Viridian Therapeutics has reported success in a second phase...
Editorial Team -
Commercial

Madrigal Licenses ARO-PNPLA3 from Arrowhead in Deal Worth Up to $1 Billion

Madrigal Pharmaceuticals has entered into a licensing agreement with...
Regulatory

Viridian’s Tepezza Competitor Hits Another Phase 3 Win; Door Opens For FDA Nod

Viridian Therapeutics has reported success in a second phase...
Clinical

Myqorzo from Cytokinetics wins historic cardiomyopathy trial

Robert Blum and Fady Malik have been with Cytokinetics...
Insights

Is Green Biotech the Future of Sustainable Drug Development?

Executive Summary Yes—green biotech is emerging as a foundational pillar...

Research & Development

Market Access

Manufacturing

Johnson & Johnson Agrees to MFN Drug Pricing and Expands U.S. Manufacturing Plans

Five months ago, Johnson & Johnson also announced plans...
Manufacturing

U.S. Biopharma Companies Advance Over $370B in Manufacturing and R&D Investments

Major drugmakers have announced more than $370 billion in...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Regulatory

Viridian’s Tepezza Competitor Hits Another Phase 3 Win; Door Opens For FDA Nod

Viridian Therapeutics has reported success in a second phase...
Editorial Team -